High Pressure Contrast Media Injectors Market Share
Some of the major market players operating in the high pressure contrast media injectors market include
Bracco Group
Medtron AG
Guerbet Group
Bayer HealthCare LLC
NemotoKyorindo Co., Ltd.
ulrich GmbH & Co. KG
GE Healthcare
Apollo RT Co. Ltd.
Sino Medical-Device Technology Co.
VIVID IMAGING
Authors:
Mariam Faizullabhoy , Pratiksha Kamthe
Frequently Asked Questions (FAQ) :
High pressure contrast media injectors industry was worth USD 176.4 million in 2022 and is estimated to generate USD 551.1 million by 2032, driven by the high incidence rate of numerous diseases along with that the rising requirement for diagnostic imaging procedures.
The consumables segment is set to grow at 11.9% CAGR by 2032 attributed to the rising prevalence of chronic diseases and the growing need for accurate diagnosis and treatment monitoring.
U.S. industry size reached USD 62.9 million in 2022 and is estimated to record considerable growth from 2023-2032 owing to the ongoing advancements in imaging technologies and the growing shift towards minimally invasive procedures.
Bracco Group, Medtron AG, Guerbet Group, Bayer HealthCare LLC, NemotoKyorindo Co., Ltd., ulrich GmbH & Co. KG, GE Healthcare, Apollo RT Co. Ltd., Sino Medical-Device Technology Co., and VIVID IMAGING are some of the major enterprises in the industry.
High Pressure Contrast Media Injectors Market Scope